Project Grant R01AI192496
Award Date
8/1/25
Completion Date
7/31/29
Dollars Obligated
$3.8M
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This $236,292 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to isolate and characterize the structure of HSV glycoprotein complexes relevant to virus entry. The 2-year project led by Tufts University School of Medicine aims to use antibodies and non-detergent extraction methods to stabilize and isolate the GD/GH/GL and GH/GL/GB glycoprotein complexes,...
This federal Project Grant award from the National Institutes of Health (NIH), under the Trans-NIH Research Support (CFDA 93.310) program, provides $1,367,863 to Emory University to conduct biophysical research on herpesvirus capsid assembly and genome packaging. The goal is to develop new methodologies to monitor these essential viral processes in real-time, which could lead to a more complete understanding of herpesviral replication and the development of improved preventative and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research on manipulating the DNA damage response and proteome on viral genomes during herpes simplex virus (HSV) infection. The $651,832 award, with a project period from November 2024 to October 2029, will enable researchers at The Children's Hospital of Philadelphia to conduct a multi-modal proteomic...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), provides $658,273 to the University of Massachusetts Medical School to study how Herpes Simplex Virus 1 (HSV-1) interacts with and regulates the NLRP1 inflammasome pathway in human skin cells. The key goals are to identify the mechanisms by which HSV-1 activates and inhibits the NLRP1 inflammasome, and to...
This federal Project Grant award, totaling $215,810.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to identify host proteins degraded in neurons by the Herpes Simplex Virus (HSV-1) and the roles of the viral proteins ICP0 and PUL55/PUL13/PUS10 in protein degradation and viral reactivation from latent infection. The primary awardee is the Rector &...
This $134,269 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research led by the Trustees of Tufts College, doing business as Tufts University School of Medicine, to characterize the structure and antigenic properties of the human cytomegalovirus (HCMV) glycoprotein B (GB) in its prefusion state. The research aims to identify and isolate novel...
This Project Grant award of $384,363.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Temple University in Philadelphia, PA. The goal of the research is to study the role of the PELLINO1 (PELI1) protein in regulating antiviral immunity in the skin epidermis, with a focus on herpes simplex virus infections. The researchers will use mouse models and human/mouse cell cultures to define...
This federal Project Grant award of $2,505,639 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand the molecular interactions between lentivirus capsids and the nuclear pore complex protein NUP358. The project aims to investigate how the binding of lentiviral capsids, including HIV-1 and HIV-2, to the RBD4-CHD didomain of NUP358 impacts viral nuclear import and replication....
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $318,085 to support research on the role of antibodies in controlling virus infections through Fc-dependent mechanisms such as antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytolysis (CDC). The research aims to elucidate the...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $525,095 to the University of Rochester to conduct research on cellular determinants of human cytomegalovirus (HCMV) infection. The research aims to identify mechanisms through which the cellular factor JUNB can restrict HCMV infection and how the viral protein UL26 modulates JUNB's activity, with the goal of...